Chundong Gu

机构：Mayo Clinic, Hong Kong Polytechnic University, Dalian Medical University, In-Q-Tel, First Affiliated Hospital of Dalian Medical University, Affiliated Zhongshan Hospital of Dalian University, Zhejiang University-University of Edinburgh Institute · ORCID：0000-0002-2981-6578

发表论文 85 篇 · 总被引 2032 次 · h-index 26

代表论文

• Erlotinib versus gemcitabine plus cisplatin as neoadjuvant treatment of stage IIIA-N2 EGFR-mutant non-small-cell lung cancer: final overall survival analysis of the EMERGING-CTONG 1103 randomised phase II trial (2023 · Signal Transduction and Targeted Therapy · 被引 82)
• Oncogenic fatty acid oxidation senses circadian disruption in sleep-deficiency-enhanced tumorigenesis (2024 · Cell Metabolism · 被引 77)
• Investigating lung cancer microenvironment from cell segmentation of pathological image and its application in prognostic stratification (2025 · Scientific Reports · 被引 6)
• UPF1 regulates FOXO1 protein expression by promoting PBK transcription in non-small cell lung cancer (2023 · Biochemical and Biophysical Research Communications · 被引 6)
• Wild-type KRAS activation drives evasion of interferon-mediated immunity and resistance to immunotherapy in hepatocellular carcinoma (2025 · Nature Communications · 被引 4)
• MACC1 ablation suppresses the dedifferentiation process of non-CSCs in lung cancer through stabilizing KLF4 (2024 · Cell Death Discovery · 被引 4)